Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation KES Poole, RL Van Bezooijen, N Loveridge, H Hamersma, ... The FASEB journal 19 (13), 1842-1844, 2005 | 1166 | 2005 |
Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist RL Van Bezooijen, BAJ Roelen, A Visser, L Van Der Wee-pals, E De Wilt, ... The Journal of experimental medicine 199 (6), 805-814, 2004 | 1115 | 2004 |
The clinical use of indocyanine green as a near‐infrared fluorescent contrast agent for image‐guided oncologic surgery BE Schaafsma, JSD Mieog, M Hutteman, JR Van der Vorst, PJK Kuppen, ... Journal of surgical oncology 104 (3), 323-332, 2011 | 943 | 2011 |
Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A MML Deckers, RL Van Bezooijen, G Van Der Horst, J Hoogendam, ... Endocrinology 143 (4), 1545-1553, 2002 | 924 | 2002 |
Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation MML Deckers, M Karperien, C van der Bent, T Yamashita, SE Papapoulos, ... Endocrinology 141 (5), 1667-1674, 2000 | 722 | 2000 |
Mesenchymal stem cells promote engraftment of human umbilical cord blood–derived CD34+ cells in NOD/SCID mice WA Noort, AB Kruisselbrink, PS in't Anker, M Kruger, RL van Bezooijen, ... Experimental hematology 30 (8), 870-878, 2002 | 669 | 2002 |
BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis M Scharpfenecker, M van Dinther, Z Liu, RL van Bezooijen, Q Zhao, ... Journal of cell science 120 (6), 964-972, 2007 | 661 | 2007 |
Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates E van Beek, E Pieterman, L Cohen, C Löwik, S Papapoulos Biochemical and biophysical research communications 264 (1), 108-111, 1999 | 659 | 1999 |
Endostatin inhibits VEGF‐induced endothelial cell migration and tumor growth independently of zinc binding N Yamaguchi, B Anand‐Apte, M Lee, T Sasaki, N Fukai, R Shapiro, I Que, ... The EMBO journal, 1999 | 616 | 1999 |
The tumor suppressor Smad4 is required for transforming growth factor β–induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells M Deckers, M van Dinther, J Buijs, I Que, C Lowik, G van der Pluijm, ... Cancer research 66 (4), 2202-2209, 2006 | 446 | 2006 |
Peroxisome proliferator-activated receptor γ (PPARγ) as a molecular target for the soy phytoestrogen genistein ZC Dang, V Audinot, SE Papapoulos, JA Boutin, CWGM Löwik Journal of Biological Chemistry 278 (2), 962-967, 2003 | 430 | 2003 |
SOST/sclerostin, an osteocyte-derived negative regulator of bone formation RL van Bezooijen, P ten Dijke, SE Papapoulos, CWGM Löwik Cytokine & growth factor reviews 16 (3), 319-327, 2005 | 418 | 2005 |
Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP‐stimulated bone formation RL Van Bezooijen, JP Svensson, D Eefting, A Visser, G van der Horst, ... Journal of Bone and Mineral Research 22 (1), 19-28, 2007 | 401 | 2007 |
Differential expression of estrogen receptors α and β mRNA during differentiation of human osteoblast SV-HFO cells J Arts, GGJM Kuiper, JMMF Janssen, JA Gustafsson, CWGM Löwik, ... Endocrinology 138 (11), 5067-5070, 1997 | 388 | 1997 |
Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro. G van der Pluijm, H Vloedgraven, E van Beek, L van der Wee-Pals, ... The Journal of clinical investigation 98 (3), 698-705, 1996 | 377 | 1996 |
Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration B Franke-Fayard, CJ Janse, M Cunha-Rodrigues, J Ramesar, P Büscher, ... Proceedings of the National Academy of Sciences 102 (32), 11468-11473, 2005 | 372 | 2005 |
Near‐infrared fluorescence‐guided resection of colorectal liver metastases JR van der Vorst, BE Schaafsma, M Hutteman, FPR Verbeek, GJ Liefers, ... Cancer 119 (18), 3411-3418, 2013 | 357 | 2013 |
Optical image-guided surgery—where do we stand? S Keereweer, JDF Kerrebijn, PBAA Van Driel, B Xie, EL Kaijzel, ... Molecular Imaging and Biology 13, 199-207, 2011 | 350 | 2011 |
In vivo imaging of transcriptionally active estrogen receptors P Ciana, M Raviscioni, P Mussi, E Vegeto, I Que, MG Parker, C Lowik, ... Nature medicine 9 (1), 82-86, 2003 | 350 | 2003 |
Toward optimization of imaging system and lymphatic tracer for near-infrared fluorescent sentinel lymph node mapping in breast cancer JSD Mieog, SL Troyan, M Hutteman, KJ Donohoe, JR Van Der Vorst, ... Annals of surgical oncology 18, 2483-2491, 2011 | 325 | 2011 |